EVIDENCE THAT A MINOR GROOVE-BINDING PEPTIDE AND A MAJOR GROOVE-BINDING PROTEIN CAN SIMULTANEOUSLY OCCUPY A COMMON SITE ON DNA

被引:39
|
作者
OAKLEY, MG [1 ]
MRKSICH, M [1 ]
DERVAN, PB [1 ]
机构
[1] CALTECH,DIV CHEM & CHEM ENGN,ARNOLD & MABEL BECKMAN LABS CHEM SYNTH,PASADENA,CA 91125
关键词
D O I
10.1021/bi00160a005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Affinity cleaving proteins have been synthesized based on the DNA-binding domain of the yeast transcriptional activator GCN4 with the DNA cleaving moiety Fe-EDTA attached at the NH2 terminus [Oakley, M. G., & Dervan, P. B. (1990) Science 248, 8471. Cleavage patterns generated by Fe.EDTA-GCN4(226-281) bound to the DNA sites 5'-CTGACTAAT-3' and 5'-ATGACTCTT-3' reveal that the NH2 termini of the GCN4 DNA-binding domain are located in the major groove of DNA, 9-10 base pairs apart, consistent with a Y-shaped dimeric structure. 1-Methylimidazole-2-carboxamide netropsin (2-ImN) is a designed synthetic peptide which binds in the minor groove of DNA at 5'-TGACT-3' sites as an antiparallel, side-by-side dimer [Mrksich, M., Wade, W. S., Dwyer, T. J., Geierstanger, B. H., Wemmer, D. E., & Dervan, P. B. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 7586]. Through the use of Fe.EDTA-GCN4(226-281) as a sequence-specific footprinting agent, it is shown that the dimeric protein GCN4(226-281) and the dimeric peptide 2-ImN can simultaneously occupy their common binding site in the major and minor grooves of DNA, respectively. The association constants for 2-ImN in the presence and in the absence of Fe.EDTA-GCN4(226-281) are found to be similar, suggesting that the binding of the two dimers is not cooperative.
引用
收藏
页码:10969 / 10975
页数:7
相关论文
共 50 条
  • [31] Effects of bifunctional netropsin-related minor groove-binding ligands on mammalian type I DNA topoisomerase
    Wang, ZY
    Zimmer, C
    Lown, JW
    Knippers, R
    BIOCHEMICAL PHARMACOLOGY, 1997, 53 (03) : 309 - 316
  • [32] A new class of symmetric bisbenzimidazole-based DNA minor groove-binding agents showing antitumor activity
    Mann, J
    Baron, A
    Opoku-Boahen, Y
    Johansson, E
    Parkinson, G
    Kelland, LR
    Neidle, S
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (02) : 138 - 144
  • [33] Brostallicin hydrochloride Minor groove-binding agent, oncolytic (vol 33, pg 478, 2008)
    Amir, E.
    Griffiths, R. W.
    Leahy, M. G.
    DRUGS OF THE FUTURE, 2008, 33 (10) : 916 - 916
  • [34] Stabilization of G-Quadruplex-Duplex Hybrid Structures Induced by Minor Groove-Binding Drugs
    Scott, Lily
    Chalikian, Tigran, V
    LIFE-BASEL, 2022, 12 (04):
  • [35] EFFECT OF SIDE-CHAINS ON THE GROOVE-BINDING SPECIFICITY OF ANTHRAQUINONE INTERCALATORS
    HUI, XW
    GRESH, N
    PULLMAN, B
    INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY, 1991, 40 : 205 - 212
  • [36] Revisiting the Association of Cationic Groove-Binding Drugs to DNA Using a Poisson-Boltzmann Approach
    Fenley, Marcia O.
    Harris, Robert C.
    Jayaram, B.
    Boschitsch, Alexander H.
    BIOPHYSICAL JOURNAL, 2010, 99 (03) : 879 - 886
  • [37] THE EFFECT OF AT AND GC SEQUENCE-SPECIFIC MINOR GROOVE-BINDING AGENTS ON RESTRICTION-ENDONUCLEASE ACTIVITY
    FORROW, SM
    LEE, M
    SOUHAMI, RL
    HARTLEY, JA
    CHEMICO-BIOLOGICAL INTERACTIONS, 1995, 96 (02) : 125 - 142
  • [38] THE INTERACTION WITH DNA OF UNFUSED AROMATIC SYSTEMS CONTAINING TERMINAL PIPERAZINO SUBSTITUENTS - INTERCALATION AND GROOVE-BINDING
    WILSON, WD
    BARTON, HJ
    TANIOUS, FA
    KONG, SB
    STREKOWSKI, L
    BIOPHYSICAL CHEMISTRY, 1990, 35 (2-3) : 227 - 243
  • [39] DNA-tethered Hoechst groove-binding agents. Duplex stabilization and fluorescence characteristics
    Wiederholt, K
    Rajur, SB
    Giuliano, J
    ODonnell, MJ
    McLaughlin, LW
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (30) : 7055 - 7062
  • [40] Pharmacokinetics of D709119 (DRH-417), a DNA minor groove-binding pyrrolobenzodiazepine monomer with a novel mechanism of action
    Wilkinson, GP
    Jenkins, TC
    Thurston, DE
    Howard, PW
    Double, JA
    Bibby, MC
    Loadman, PM
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S28 - S28